Effect of maternal obesity on breast cancer among offspring: role of the gut microbiota
母亲肥胖对后代乳腺癌的影响:肠道微生物群的作用
基本信息
- 批准号:10734892
- 负责人:
- 金额:$ 35.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-15 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdverse effectsAffectAgeAgonistAir PollutionAllograftingAmerican IndiansAntibioticsBacteriaBiologicalBiological SciencesBirthBlack raceBreast Cancer CellBreast Cancer ModelBreast Cancer Risk FactorC57BL/6 MouseCD8-Positive T-LymphocytesCRISPR/Cas technologyCell physiologyCellsChildClinicalClostridiaceaeCognitiveCommunitiesConsumptionCrimeDaughterDiabetes MellitusDietary FiberDietary InterventionDiscipline of NursingEmotionalEndocrinologyEtiologyExposure toFFAR2 geneFFAR3 geneFemaleFemale of child bearing ageFetal TissuesFiberFunctional disorderGenerationsGoalsGrowthHumanImmuneImmunityImpairmentIncidenceIndividualInflammationInflammatoryInterventionIntervention StudiesInulinKnock-outKnockout MiceLifeLinkLong-Term EffectsMammary NeoplasmsMammary TumorigenesisMass Spectrum AnalysisMeasuresMediatingMetabolismMicrobeMinnesotaMouse Mammary Tumor VirusMusNot Hispanic or LatinoObesityObesity EpidemicOrganOutcomePlayPredispositionPregnancyPregnant WomenPrevention strategyPrevotellaProbioticsProductionPublic HealthReportingRiskRoleShotgunsSignal TransductionTestingTissuesTransplantationTumor-infiltrating immune cellsVolatile Fatty AcidsWhole BloodWomananti-tumor immune responsecell typeclinical translationdiet-induced obesitydietarydietary controldrinking watereffective interventionfecal microbiotafecal transplantationgut bacteriagut dysbiosisgut microbesgut microbiotahealth disparityimmune cell infiltrateimmune functioninflammatory markerlow socioeconomic statusmalignant breast neoplasmmammarymaternal obesitymetagenomic sequencingmitochondrial metabolismmortalityobese mothersobesity in pregnancyoffspringpolyoma middle tumor antigenpregnantpreventprogramsreceptorstem cell differentiationwestern diet
项目摘要
In Minnesota, American Indian (34.1%) and non-Hispanic Black (33.4%) women are over twice as likely to be
obese during pregnancy than non-Hispanic White women of whom 16.6% are obese during pregnancy. This
high incidence reflects the causes of maternal obesity such as low socioeconomic status, high crime rate, and
excess exposure to air pollution. Maternal obesity has widespread adverse effects on the offspring including
increasing their risk of dying from breast cancer. Maternal obesity also permanently disrupts the mutually
beneficial interaction between the offspring and offspring’s gut microbiota, causing gut dysbiosis. Gut dysbiosis
in the offspring is characterized by a reduction in the gut bacteria that produce fecal short-chain fatty acids
(SCFA). SCFAs play pivotal roles in maintaining healthy immune functions, cellular metabolism, and other critical
functions. These compounds act mostly through their receptors GPR43 and GPR41, which are expressed in
immune cells and multiple other cell types. Here, we will test the central hypothesis that the composition of
commensal gut microbes in the offspring of obese dams is causally responsible for an offspring’s increased
susceptibility to mammary tumorigenesis, an effect that likely also reflects altered immunity. We will test this
causal link by performing fecal microbiota transfers (FMTs). The role of GPR43 and GPR41 in mediating the
impact of maternal obesity on offspring will be tested using CRISPR/Cas9 knockout mice. The potential for
clinical translation of our findings will be established by supplementing obese pregnant dams with a commercially
available probiotic mix of SCFA-producing gut bacteria and dietary fiber that increases SCFA production. Such
a combination has been earlier found to be most effective in reversing loss of critical microbes of healthy gut
microbiota from individuals who have consumed an unhealthy Western diet for multiple generations. We will use
allografted E0771 and Py230 mammary tumor models and MMTV-PyMT mice developing mammary tumors at
about age 3 months. Shotgun metagenome sequencing and mass spectrometry will be applied to study gut
microbiota and their metabolites, respectively. Changes in immune cell infiltration and activity will be measured
in multiple tissues and compared with the expression of GPR43 and GPR41 in immune cells. Our studies could
lead to effective and safe prevention strategies against breast cancer and its growth in the daughters of obese
mothers, and be particularly beneficial for communities suffering from health disparities.
在明尼苏达州,美国印第安人(34.1%)和非西班牙裔黑人(33.4%)女性患病的可能性是前者的两倍多
怀孕期间肥胖的妇女多于非西班牙裔白人妇女,其中16.6%的妇女在怀孕期间肥胖。这
高发病率反映了母亲肥胖的原因,如社会经济地位低,犯罪率高,以及
过度暴露在空气污染中。母亲肥胖对后代有广泛的不利影响,包括
增加了他们死于乳腺癌的风险。母亲肥胖也永久性地扰乱了相互之间的
后代和后代的肠道微生物群之间的有益相互作用,导致肠道生态失调。肠道菌群失调
在后代中的特征是产生粪便短链脂肪酸的肠道细菌减少
(SCFA)。单链脂肪酸在维持健康的免疫功能、细胞代谢和其他关键的
功能。这些化合物主要通过它们的受体GPR43和GPR41发挥作用,这两种受体在
免疫细胞和多种其他类型的细胞。在这里,我们将检验核心假设,即
肥胖母鸡后代中的共生肠道微生物是导致后代体重增加的原因
对乳腺肿瘤的易感性,这种影响可能也反映了免疫力的改变。我们将对此进行测试
通过进行粪便微生物区系转移(FMT)而产生的因果联系。GPR43和GPR41在调节血管紧张素转换酶中的作用
母体肥胖对后代的影响将使用CRISPR/Cas9基因敲除小鼠进行测试。潜在的
我们的发现的临床翻译将通过向肥胖怀孕的大坝补充商业上的一种
产生超临界脂肪酸的肠道细菌和膳食纤维的有效益生菌混合物,可增加超临界脂肪酸的产量。是这样的
早些时候已经发现,一种组合在逆转健康肠道中关键微生物的损失方面最有效
来自几代人食用不健康西方饮食的人的微生物区系。我们将使用
同种异体移植E0771和PY230乳腺肿瘤模型及MMTV-PYMT小鼠发生乳腺肿瘤
大约3个月大。鸟枪式超基因组测序和质谱学将应用于肠道研究
微生物区系及其代谢物。将测量免疫细胞渗透和活性的变化
并与GPR43和GPR41在免疫细胞中的表达进行比较。我们的研究可以
引导有效和安全的预防策略,预防肥胖女性的乳腺癌及其生长
这对于健康差距较大的社区尤其有益。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LEENA A. HILAKIVI-CLARKE其他文献
LEENA A. HILAKIVI-CLARKE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LEENA A. HILAKIVI-CLARKE', 18)}}的其他基金
Improving response to immunotherapy by genistein and antiestrogens
改善金雀异黄素和抗雌激素免疫疗法的反应
- 批准号:
10112524 - 财政年份:2021
- 资助金额:
$ 35.46万 - 项目类别:
Transgenerational effects of maternal high fat diet during pregnancy on breast ca
孕期母亲高脂肪饮食对乳腺癌的跨代影响
- 批准号:
8543663 - 财政年份:2012
- 资助金额:
$ 35.46万 - 项目类别:
Transgenerational effects of maternal high fat diet during pregnancy on breast ca
孕期母亲高脂肪饮食对乳腺癌的跨代影响
- 批准号:
8321741 - 财政年份:2012
- 资助金额:
$ 35.46万 - 项目类别:
Transgenerational effects of maternal high fat diet during pregnancy on breast ca
孕期母亲高脂肪饮食对乳腺癌的跨代影响
- 批准号:
8706830 - 财政年份:2012
- 资助金额:
$ 35.46万 - 项目类别:
Early Life Estrogenicity and Mammary Cancer Risk
生命早期雌激素和乳腺癌风险
- 批准号:
8180999 - 财政年份:2010
- 资助金额:
$ 35.46万 - 项目类别:
Genome wide methylation arrays for detecting markers of increased susceptibility
用于检测易感性增加标记物的全基因组甲基化阵列
- 批准号:
7934998 - 财政年份:2009
- 资助金额:
$ 35.46万 - 项目类别:
In utero dietary exposure to endocrine disruptors
子宫内饮食接触内分泌干扰物
- 批准号:
7192451 - 财政年份:2005
- 资助金额:
$ 35.46万 - 项目类别:
In utero dietary exposure to endocrine disruptors and l*
在子宫内饮食中接触内分泌干扰物和 l*
- 批准号:
7060414 - 财政年份:2005
- 资助金额:
$ 35.46万 - 项目类别:
In utero dietary exposure to endocrine disruptors
子宫内饮食接触内分泌干扰物
- 批准号:
6940954 - 财政年份:2005
- 资助金额:
$ 35.46万 - 项目类别:
Timing of dietary exposure and breast cancer risk
饮食暴露时间与乳腺癌风险
- 批准号:
6802869 - 财政年份:2003
- 资助金额:
$ 35.46万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 35.46万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 35.46万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 35.46万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 35.46万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 35.46万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 35.46万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 35.46万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 35.46万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 35.46万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 35.46万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




